Study title:
A multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy of Biobypass (ADGVVEGF121.10NH) delivered by NOGATM-guided/MYOSTARTM catheter in "no option" patients with class II-IV stable angina
Date receipt dossier:
5 jul 2005
EudraCT number:
2004-001250-91
Pharmaceutical study code:
GV-002.001 (NOVA trial)
Company / Sponsor:
GenVec, Inc.
Phase:
II
Treated organism:
Humans
Indication category:
Cardiovascular therapy
Disease:
Stable angina pectoris
Therapeutic approach:
Gene therapy
Genetic modification:
human VEGF121
Method of transfer of nucleic acid of interest:
Human Adenovirus serotype 5
Administered biological material:
Recombinant Adenovirus D (E1a and partially E1b and E3)
Route of administration:
Intracardiac
Locations in Belgium:
AZ Middelheim, Antwerpen
Type of procedure:
Contained use only
Notes:
study withdrawn by notifier